Background: Co-infections of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) with respiratory viruses, bacteria and fungi have been reported to cause a wide range of …

Aims During the ongoing COVID-19 outbreak, co-circulation of other common respiratory
viruses can potentially result in co-infections; however, reported rates of co-infections for …

Objectives Our work assessed the prevalence of co‐infections in patients with SARS‐CoV‐
2. Methods All patients hospitalized in a Parisian hospital during the first wave of COVID‐19 …

Co-infection with additional pathogens is a well-known feature of pandemics. We
determined the prevalence and type of a wide variety of respiratory pathogens in 12,075 …

To the Editor, We have recently read the article by Chaung et al 1 describing a case of SARS‐
CoV‐2 and HCoV‐HKU1 coinfection. The HCoV‐HKU1 is also a member of the …

The global coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in an unprecedented …

The aim of this systematic review and meta‐analysis was to critically assess the published
literature related to community‐acquired viral co‐infections and COVID‐19 and to evaluate …

Infection with the new pandemic pathogen severe acute respiratory syndrome coronavirus‐2
(SARS‐CoV‐2) can cause a wide range of disease varying from mild cold‐like symptoms to …

Objectives The effect of SARS-CoV-2 on existing respiratory viruses in circulation and the
overall burden of viral respiratory disease remains uncertain. Traditionally, severe viral …

Τhe COVID-19 pandemic highly impacted the circulation, seasonality, and morbidity burden
of several respiratory viruses. We reviewed published cases of SARS-CoV-2 and respiratory …